The role of PGP9.5 as a tumor suppressor gene in human cancer.
about
Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation.Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer.Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinomaUbiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions.A combination of two electrophoretical approaches for detailed proteome-based characterization of SCLC subtypes.Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.Automated PGP9.5 immunofluorescence staining: a valuable tool in the assessment of small fiber neuropathy?Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer.DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinomaBronchial airway gene expression in smokers with lung or head and neck cancer.Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Role of DNA methylation in head and neck cancer.Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.Clinical neuropathology practice guide 5-2013: markers of neuronal maturation.Immunocytochemical markers of neuronal maturation in human diagnostic neuropathology.Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylationFrequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
P2860
Q30317812-7521E723-0DF9-47B1-B206-C6FB7E063649Q33799710-FF5A919B-BC88-45B3-80C4-3D0D3C6AB849Q33920324-22F27931-8C58-4DBC-BDA3-3059985C4979Q34058385-728DAB35-E82F-4567-A2FC-9CA187D7DDF4Q34200303-7E964842-0B0F-4DF6-B2AE-1A82D7BCF90FQ34228778-346A977F-4F45-485C-A680-D94EBE935A27Q34708747-E97DCD7F-844B-43A8-A681-3324964FA934Q35004607-84967627-136E-4443-8612-63237CF9EE59Q36027109-4C90BC4C-6008-4B13-82DB-41759FB9039EQ36136842-A8AE5490-A3B8-4CF6-B897-465E7C68D8E0Q36221083-ED9FECBD-D2E7-48E0-B3C0-78F9828EC79CQ36300261-BE61C017-E4C7-4921-A14C-25478DB7F6A1Q36464299-51815F86-6375-479F-AEFE-71D2004FCE52Q36715039-A40061EE-60AF-4BC2-8411-4E396849A29EQ37481100-6285514C-63CB-4538-BEF0-495118437447Q37703387-29A6F410-AD7D-451C-AD3C-DF115046E8DBQ37824622-9786E890-A713-453E-A8EE-09AECBF1E512Q38019157-7E21A4AA-E618-48A6-BB37-5035A021CC00Q38071897-9E5FE6D5-3329-4B3D-A30F-86C5C75DBB89Q38123912-3937734D-5573-4B56-8D57-E941C30DB3EDQ38250190-78BB1BB9-DAE1-47CE-9E4E-F61DF1503F72Q38565170-CBCB02A6-65A7-452A-962E-7E8D339285DCQ39019302-874CF225-BE3A-45E3-8E9E-A73ECDFBFA08Q39533559-39B7F0C8-96D7-4080-975C-61BD90D79B55Q39611471-C61797D1-D6E0-44F9-B612-C272899091C3Q43570380-F54D4473-B397-4283-B1A3-64DA365EF5B2Q47592158-F3781DA8-3027-4C7C-90F4-EBBF4D1F0A49
P2860
The role of PGP9.5 as a tumor suppressor gene in human cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@en
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@nl
type
label
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@en
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@nl
prefLabel
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@en
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@nl
P2093
P2860
P356
P1476
The role of PGP9.5 as a tumor suppressor gene in human cancer.
@en
P2093
David Sidransky
Hannah L Park
Keishi Yamashita
Masaki Mori
Motonobu Osada
Myoung Sook Kim
Yutaka Tokumaru
P2860
P304
P356
10.1002/IJC.23354
P577
2008-08-01T00:00:00Z